Chronic β-adrenoceptor antagonists upregulate the rat alveolar macrophage adrenergic system through the β 1 -subtype

Cellular Physiology and Biochemistry

Volumn 28, Issue 2, 2011, Pages 315-322

  Guo, Yue Ping ^a   Liu, Yan ^b   Li, Jing Bo ^a   Huang, Yun ^a   Qi, Han Ping ^b   Xie, Jing ^b   Cui, Xiao Guang ^a   Yue, Zi Yong ^a   Li, Wen Zhi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Department of Pharmacology ^*  (United Kingdom)

Author keywords

Alveolar macrophages; Atenolol; Propranolol

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DOPAMINE BETA MONOOXYGENASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NORADRENALIN; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING;

RATTUS;

EID: 80052095872     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000331747     Document Type: Article

References (25)

1. Marriott HM, Dockrell DH: The role of the macrophage in lung disease mediated by bacteria. Exp Lung Res 2007;33:493-505. (Pubitemid 350256094)
2. Chao J, Wood JG, Gonzalez NC: Alveolar hypoxia, alveolar macrophages, and systemic inflammation. Respir Res 2009;10:54.
3. Gonzalez NC, Allen J, Blanco VG, Schmidt EJ, van Rooijen N, Wood JG: Alveolar macrophages are necessary for the systemic inflammation of acute alveolar hypoxia. J Appl Physiol 2007;103:1386-1394. (Pubitemid 47605978)
4. Deng J, Muthu K, Gamelli R, Shankar R, Jones SB: Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis. Am J Physiol Cell Physiol 2004;287:C730-736. (Pubitemid 39095860)
5. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, Gao H, Van Rooijen N, Huber-Lang MS, Neubig RR, Ward PA: Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007;449:721-725. (Pubitemid 47552095)
6. Engler KL, Rudd ML, Ryan JJ, Stewart JK, Fischer-Stenger K: Autocrine actions of macrophage-derived catecholamines on interleukin-1 beta. J Neuroimmunol 2005;160:87-91. (Pubitemid 40248597)
7. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
8. McCourtie AS, Merry HE, Farivar AS, Goss CH, Mulligan MS: Alveolar macrophage secretory products augment the response of rat pulmonary artery endothelial cells to hypoxia and reoxygenation. Ann Thorac Surg 2008;85:1056-1060. (Pubitemid 351253515)
9. Donnelly LE, Tudhope SJ, Fenwick PS, Barnes PJ: Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. Eur Respir J 2010;36:178-186.
10. Brodde OE: Beta-adrenoceptor blocker treatment and the cardiac betaadrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure. Naunyn Schmiedebergs Arch Pharmacol 2007;374:361-372.
11. Brodde OE, Bruck H, Leineweber K: Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci 2006;100:323-337. (Pubitemid 44609527)
12. Bangalore S, Messerli FH, Kostis JB, Pepine CJ: Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol 2007;50:563-572. (Pubitemid 47202065)
13. Haeusler G.: Pharmacology of betablockers: classical aspects and recent developments. J Cardiovasc Pharmacol 1990;16:S1-S9.
14. Glaubiger G, Lefkowitz RJ: Elevated betaadrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun 1977;78:720-725. (Pubitemid 8214741)
15. Baker SP, Potter LT. Effect of propranolol on beta-adrenoceptors in rat hearts. Br J Pharmacol 1980;68:8-10. (Pubitemid 10183209)
16. Baker SP, Katovich MJ: Chronic propranolol treatment decreases cardiac beta-adrenoceptors in spontaneously hypertensive rats. Eur J Pharmacol 1982;78:479-482. (Pubitemid 12143020)
17. Tan YY, Summers RJ: beta-Adrenoceptor regulation in rat heart, lung and skin after chronic treatment with (-)-tertatolol or (-)-propranolol. J Auton Pharmacol 1995;15:421-436.
18. Bouzamondo A, Hulot JS, Sanchez P, Cucherat M, Lechat P: Beta-blocker treatment in heart failure. Fundam Clin Pharmacol 2001;15:95-109. (Pubitemid 34592050)
19. Miller LE, Jüsten HP, Schölmerich J, Straub RH: The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000;14:2097-2107.
20. Chiladakis JA, Georgiopoulou E, Alexopoulos D: Autonomic effects of nebivolol versus atenolol in healthy subjects. Cardiovasc Drugs Ther 2004;18:469-473. (Pubitemid 40487025)
21. Jarai R, Kaun C, Weiss TW, Speidl WS, Rychli K, Maurer G, Huber K, Wojta J: Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta. J Cell Mol Med 2009;13:4415-4421.
22. Loppnow H, Zhang L, Buerke M, Lautenschläger M, Chen L, Frister A, Schlitt A, Luther T, Song N, Hofmann B, Rose-John S, Silber RE, Müller-Werdan U, Werdan K: Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures. J Cell Mol Med 2011;15:994-1004
23. Kageyama K, Kagaya S, Takayasu S, Hanada K, Iwasaki Y, Suda T: Cytokines induce NF-κB, Nurr1 and corticotropinreleasing factor gene transcription in hypothalamic 4B cells. Neuroimmunomodulation 2010;17:305-313.
24. Haedo MR, Gerez J, Fuertes M, Giacomini D, Páez-Pereda M, Labeur M, Renner U, Stalla GK, Arzt E: Regulation of pituitary function by cytokines. Horm Res 2009;72:266-274.
25. Grisanti LA, Evanson J, Marchus E, Jorissen H, Woster AP, DeKrey W, Sauter ER, Combs CK, Porter JE: Proinflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent. Mol Immunol 2010;47:1244-1254.